Judi Health valuation, funding and investors

Judi Health works in health benefit management services, based in Jersey City, United States. Founded in 2017, it has about 56 employees.

Insurance - Agents, Carriers & Brokers Series F

VALUATION · TODAY

$4.22B +0% after Series F

Range $2.70B – $4.86B · Grade A

TODAY

+12 MO

$2.00B

$4.00B

$6.00B

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Growth $12.0M

Series B $50.0M

Series C $106M

Growth $50.0M

Series F $400M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY56 employees

−91%6m growth

−91%1y growth

−90%2y growth

250

500

750

Data from Jan 2021

TODAY

Predicted in 1 yr $4.22B +0% vs today

Predicted next raise $465M if a round comes

Winding-down probability 0%

Last round: Series F · $400M · Sep 2025
Valuation at last round: $3.25B
Headcount: 56
Grade: A
Founded: 2017

How VCMC values companies →

Judi Health valuation today

VCMC values Judi Health at $4.2B today, with a range of $2.7B to $4.9B and a grade of A. The valuation starts from its last funding round, a Series F round in Sep 2025.

Valuation by date (124 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Judi Health: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2017	$8.37M	$3.05M – $23.0M	$11.5M (+37%)	before first round	–	unknown	D	0%
1 Feb 2017	$8.60M	$3.13M – $23.6M	$11.8M (+37%)	before first round	–	unknown	D	0%
1 Mar 2017	$8.81M	$3.21M – $24.2M	$12.1M (+37%)	before first round	–	unknown	D	0%
1 Apr 2017	$9.05M	$3.29M – $24.9M	$12.4M (+37%)	before first round	–	unknown	D	0%
1 May 2017	$9.29M	$3.38M – $25.5M	$12.7M (+37%)	before first round	–	unknown	D	0%
1 Jun 2017	$9.54M	$3.47M – $26.2M	$13.1M (+37%)	before first round	–	unknown	D	0%
1 Jul 2017	$9.79M	$3.56M – $26.9M	$13.4M (+37%)	before first round	–	unknown	D	0%
1 Aug 2017	$10.1M	$3.66M – $27.6M	$13.8M (+37%)	before first round	–	unknown	D	0%
1 Sep 2017	$10.3M	$3.76M – $28.4M	$14.2M (+37%)	before first round	–	unknown	D	0%
1 Oct 2017	$10.6M	$3.86M – $29.1M	$14.5M (+37%)	before first round	–	unknown	D	0%
1 Nov 2017	$10.9M	$3.96M – $29.9M	$14.9M (+37%)	before first round	–	unknown	D	0%
1 Dec 2017	$11.2M	$4.07M – $30.7M	$15.3M (+37%)	before first round	–	unknown	D	0%
1 Jan 2018	$11.5M	$4.18M – $31.5M	$15.7M (+37%)	before first round	–	unknown	D	0%
1 Feb 2018	$11.8M	$4.29M – $32.4M	$16.2M (+37%)	before first round	–	unknown	D	0%
1 Mar 2018	$12.1M	$4.40M – $33.2M	$16.6M (+37%)	before first round	–	unknown	D	0%
1 Apr 2018	$12.4M	$4.52M – $34.1M	$17.0M (+37%)	before first round	–	unknown	D	0%
1 May 2018	$12.7M	$4.64M – $35.0M	$17.5M (+37%)	before first round	–	unknown	D	0%
1 Jun 2018	$13.1M	$4.76M – $35.9M	$17.9M (+37%)	before first round	–	unknown	D	0%
1 Jul 2018	$13.4M	$4.89M – $36.9M	$18.4M (+37%)	before first round	–	unknown	D	0%
1 Aug 2018	$13.8M	$5.02M – $37.9M	$18.6M (+35%)	before first round	–	unknown	D	0%
1 Sep 2018	$14.2M	$5.15M – $38.9M	$18.8M (+32%)	before first round	–	unknown	D	0%
1 Oct 2018	$14.5M	$5.29M – $39.9M	$18.9M (+30%)	before first round	–	unknown	D	0%
1 Nov 2018	$14.9M	$5.43M – $41.0M	$19.1M (+28%)	before first round	–	unknown	D	0%
1 Dec 2018	$15.3M	$5.58M – $42.1M	$19.3M (+26%)	before first round	–	unknown	D	0%
1 Jan 2019	$15.7M	$5.73M – $43.2M	$19.4M (+24%)	before first round	–	unknown	D	0%
1 Feb 2019	$16.2M	$5.88M – $44.4M	$19.6M (+21%)	before first round	–	unknown	D	0%
1 Mar 2019	$16.6M	$6.03M – $45.5M	$19.8M (+19%)	before first round	–	unknown	D	0%
1 Apr 2019	$17.0M	$6.19M – $46.7M	$20.0M (+17%)	before first round	–	unknown	D	0%
1 May 2019	$17.5M	$6.35M – $47.9M	$20.1M (+15%)	before first round	–	unknown	D	0%
1 Jun 2019	$17.9M	$6.53M – $49.3M	$20.3M (+13%)	before first round	–	unknown	D	0%
1 Jul 2019	$18.4M	$6.70M – $50.5M	$20.5M (+11%)	before first round	–	unknown	D	0%
17 Jul 2019	$133M	$87.6M – $223M	$147M (+10%)	after a round	–	unknown	B	0%
1 Aug 2019	$134M	$87.6M – $223M	$147M (+10%)	after a round	–	unknown	B	0%
1 Sep 2019	$135M	$87.6M – $223M	$147M (+9%)	after a round	–	unknown	B	0%
1 Oct 2019	$136M	$87.6M – $223M	$147M (+8%)	after a round	–	unknown	B	0%
1 Nov 2019	$137M	$87.6M – $223M	$147M (+7%)	after a round	–	unknown	B	0%
1 Dec 2019	$138M	$87.6M – $223M	$147M (+6%)	after a round	–	unknown	B	0%
1 Jan 2020	$139M	$87.6M – $223M	$147M (+5%)	after a round	–	unknown	B	0%
1 Feb 2020	$140M	$87.6M – $223M	$147M (+4%)	after a round	–	unknown	B	0%
1 Mar 2020	$142M	$87.6M – $223M	$147M (+4%)	after a round	–	unknown	B	0%
1 Apr 2020	$143M	$87.6M – $223M	$147M (+3%)	after a round	–	unknown	B	0%
1 May 2020	$144M	$87.6M – $223M	$147M (+2%)	after a round	–	unknown	B	0%
1 Jun 2020	$145M	$87.6M – $223M	$147M (+1%)	after a round	–	unknown	B	0%
1 Jul 2020	$146M	$87.6M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Aug 2020	$147M	$85.2M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Sep 2020	$147M	$81.0M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Oct 2020	$147M	$77.1M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Nov 2020	$147M	$73.3M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Dec 2020	$147M	$69.8M – $223M	$147M (0%)	after a round	–	unknown	B	0%
1 Jan 2021	$147M	$66.3M – $223M	$147M (0%)	after a round	99	unknown	C	0%
1 Feb 2021	$147M	$63.0M – $223M	$147M (0%)	after a round	99	unknown	C	0%
3 Feb 2021	$306M	$215M – $650M	$458M (+50%)	after a round	99	unknown	B	0%
1 Mar 2021	$315M	$215M – $650M	$458M (+46%)	after a round	99	unknown	B	0%
1 Apr 2021	$326M	$215M – $650M	$458M (+41%)	after a round	99	flat	B	0%
1 May 2021	$337M	$215M – $650M	$458M (+36%)	after a round	99	flat	B	0%
1 Jun 2021	$349M	$215M – $650M	$458M (+31%)	after a round	99	flat	B	0%
1 Jul 2021	$360M	$215M – $650M	$458M (+27%)	after a round	99	flat	B	0%
1 Aug 2021	$373M	$215M – $650M	$458M (+23%)	after a round	99	flat	B	0%
1 Sep 2021	$386M	$215M – $650M	$458M (+19%)	after a round	99	flat	B	0%
1 Oct 2021	$399M	$215M – $650M	$458M (+15%)	after a round	99	flat	B	0%
1 Nov 2021	$413M	$215M – $650M	$458M (+11%)	after a round	99	flat	B	0%
1 Dec 2021	$427M	$215M – $650M	$458M (+7%)	after a round	99	flat	B	0%
1 Jan 2022	$442M	$215M – $650M	$458M (+4%)	after a round	99	flat	B	0%
1 Feb 2022	$457M	$215M – $650M	$458M (0%)	after a round	99	flat	B	0%
1 Mar 2022	$458M	$207M – $650M	$458M (0%)	after a round	99	flat	B	0%
1 Apr 2022	$601M	$289M – $853M	$601M (0%)	after a round	340	growing	B	0%
1 May 2022	$601M	$292M – $853M	$601M (0%)	after a round	340	growing	B	0%
1 Jun 2022	$601M	$296M – $853M	$601M (0%)	after a round	340	growing	B	0%
14 Jun 2022	$847M	$597M – $1.6B	$1.1B (+30%)	after a round	340	growing	B	0%
1 Jul 2022	$858M	$597M – $1.6B	$1.1B (+28%)	after a round	340	growing	B	0%
1 Aug 2022	$877M	$597M – $1.6B	$1.1B (+26%)	after a round	340	growing	B	0%
1 Sep 2022	$897M	$597M – $1.6B	$1.1B (+23%)	after a round	340	growing	B	0%
1 Oct 2022	$916M	$597M – $1.6B	$1.1B (+20%)	after a round	340	growing	B	0%
1 Nov 2022	$937M	$597M – $1.6B	$1.1B (+17%)	after a round	340	unknown	B	0%
1 Dec 2022	$957M	$597M – $1.6B	$1.1B (+15%)	after a round	340	unknown	B	0%
1 Jan 2023	$996M	$615M – $1.6B	$1.1B (+14%)	after a round	390	up	B	0%
1 Feb 2023	$1.0B	$615M – $1.6B	$1.1B (+11%)	after a round	390	up	B	0%
1 Mar 2023	$1.0B	$615M – $1.6B	$1.1B (+9%)	after a round	390	up	B	0%
1 Apr 2023	$1.1B	$615M – $1.6B	$1.1B (+6%)	after a round	390	up	B	0%
1 May 2023	$1.1B	$615M – $1.6B	$1.1B (+4%)	after a round	390	up	B	0%
1 Jun 2023	$1.1B	$615M – $1.6B	$1.1B (+1%)	after a round	390	up	B	0%
1 Jul 2023	$1.1B	$611M – $1.6B	$1.1B (0%)	after a round	390	up	B	0%
1 Aug 2023	$1.1B	$604M – $1.6B	$1.1B (0%)	after a round	390	up	B	0%
1 Sep 2023	$1.1B	$597M – $1.6B	$1.1B (0%)	after a round	390	up	B	0%
1 Oct 2023	$1.2B	$607M – $1.7B	$1.2B (0%)	after a round	440	up	B	0%
12 Oct 2023	$556M	$365M – $930M	$611M (+10%)	after a round	440	up	B	0%
1 Nov 2023	$559M	$365M – $930M	$611M (+9%)	after a round	440	up	B	0%
1 Dec 2023	$563M	$365M – $930M	$611M (+9%)	after a round	440	up	B	0%
1 Jan 2024	$568M	$365M – $930M	$611M (+8%)	after a round	440	up	B	0%
1 Feb 2024	$576M	$374M – $952M	$626M (+9%)	after a round	490	up	B	0%
1 Mar 2024	$583M	$375M – $957M	$629M (+8%)	after a round	500	up	B	0%
1 Apr 2024	$589M	$375M – $957M	$629M (+7%)	after a round	500	up	B	0%
1 May 2024	$595M	$375M – $957M	$629M (+6%)	after a round	500	up	B	0%
1 Jun 2024	$601M	$375M – $957M	$629M (+5%)	after a round	500	up	B	0%
1 Jul 2024	$607M	$375M – $957M	$629M (+3%)	after a round	500	up	B	0%
1 Aug 2024	$630M	$388M – $988M	$649M (+3%)	after a round	580	up	B	0%
1 Sep 2024	$639M	$388M – $988M	$649M (+2%)	after a round	580	up	B	0%
1 Oct 2024	$647M	$388M – $988M	$649M (0%)	after a round	580	up	B	0%
1 Nov 2024	$661M	$393M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 Dec 2024	$661M	$390M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 Jan 2025	$661M	$387M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 Feb 2025	$661M	$384M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 Mar 2025	$661M	$381M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 Apr 2025	$661M	$378M – $1.0B	$661M (0%)	after a round	630	growing	B	0%
1 May 2025	$661M	$329M – $1.0B	$661M (0%)	after a round	630	up	B	0%
1 Jun 2025	$661M	$320M – $1.0B	$661M (0%)	after a round	630	up	B	0%
1 Jul 2025	$661M	$312M – $1.0B	$661M (0%)	after a round	630	up	B	0%
1 Aug 2025	$661M	$303M – $1.0B	$661M (0%)	after a round	630	up	B	0%
1 Sep 2025	$661M	$295M – $1.0B	$661M (0%)	after a round	630	up	C	0%
24 Sep 2025	$3.3B	$2.8B – $4.9B	$4.2B (+30%)	after a round	630	flat	A	0%
1 Oct 2025	$3.3B	$2.8B – $4.9B	$4.2B (+29%)	after a round	630	flat	A	0%
1 Nov 2025	$3.3B	$2.8B – $4.9B	$4.2B (+26%)	after a round	630	flat	A	0%
1 Dec 2025	$3.4B	$2.8B – $4.9B	$4.2B (+24%)	after a round	630	flat	A	0%
1 Jan 2026	$3.5B	$2.8B – $4.9B	$4.2B (+21%)	after a round	630	flat	A	0%
1 Feb 2026	$3.6B	$2.8B – $4.9B	$4.2B (+18%)	after a round	630	flat	A	0%
1 Mar 2026	$3.6B	$2.8B – $4.9B	$4.2B (+16%)	after a round	630	unknown	A	0%
1 Apr 2026	$3.7B	$2.8B – $4.9B	$4.2B (+13%)	after a round	630	unknown	A	0%
1 May 2026	$3.8B	$2.8B – $4.9B	$4.2B (+11%)	after a round	630	unknown	A	0%
1 Jun 2026	$3.9B	$2.8B – $4.9B	$4.2B (+9%)	after a round	630	unknown	A	0%
1 Jul 2026	$4.0B	$2.8B – $4.9B	$4.2B (+6%)	after a round	630	unknown	A	0%
1 Aug 2026	$4.1B	$2.8B – $4.9B	$4.2B (+4%)	after a round	630	unknown	A	0%
1 Sep 2026	$4.2B	$2.8B – $4.9B	$4.2B (+2%)	after a round	630	unknown	A	0%
1 Oct 2026	$4.2B	$2.8B – $4.9B	$4.2B (0%)	after a round	56	unknown	A	0%
24 Oct 2026	$4.2B	$2.7B – $4.9B	$4.2B (0%)	after a round	56	unknown	A	0%

Key facts about Judi Health

Founded: 2017
Headquarters: Jersey City, United States
Employees: about 56
Total raised: $618M
Funding rounds: 5
Last round: Series F Sep 2025

Judi Health was founded in 2017 by A. J. Loiacono and Bryan Birch.

Judi Health funding history

Judi Health has 5 funding rounds on record, from Jul 2019 to Sep 2025, $618M in total. The latest disclosed valuation is $3.25B post-money (Series F, Sep 2025).

Series F 23 Sep 2025
Led by Wellington Management, General Catalyst; with Generation Investment Management, Growth Equity at Goldman Sachs Alternatives, 9Yards Capital, B Capital, Edison Partners, Prime Health Investments, Transformation Capital.
Sources: judi.health, prnewswire.com, hlth.com and 3 more
$400M
$3.25B post-money
Growth Equity 11 Oct 2023
Led by Transformation Capital; with Atlantic Health System, Banner Health, Hawai'i Pacific Health, Inova Health System, Lehigh Valley Health Network, Memorial Hermann Health System, Nebraska Medicine, Novant Health, Ochsner Health, WellSpan Health, Ochsner Ventures.
Sources: fiercehealthcare.com
$50M
Series C 13 Jun 2022
Led by B Capital; with General Catalyst, Transformation Capital, Edison Partners.
Sources: prnewswire.com, fiercehealthcare.com, accessmarketintell.com and 3 more
$106M
Series B 2 Feb 2021
Led by Transformation Capital; with Edison Partners.
Sources: finsmes.com, fiercehealthcare.com, alleywatch.com and 2 more
$50M
Growth Equity 16 Jul 2019
Led by Edison Partners.
Sources: finsmes.com, edisonpartners.com, pulse2.com and 1 more
$12M

Judi Health investors

20 investors have backed Judi Health; Edison Partners, Transformation Capital and B Capital and 2 more led at least one round.

Edison Partners lead, 4 rounds
B Capital lead, 2 rounds
General Catalyst lead, 2 rounds
Wellington Management lead
9Yards Capital
Atlantic Health System
Banner Health
Generation Investment Management
Growth Equity at Goldman Sachs Alternatives
Hawai'i Pacific Health
Inova Health System
Lehigh Valley Health Network
Memorial Hermann Health System
Nebraska Medicine
Novant Health
Ochsner Health
Ochsner Ventures
Prime Health Investments
WellSpan Health

What Judi Health does

Judi Health works in insurance - agents, carriers & brokers, with 9 recorded offerings and customers in healthcare.

Capital Rx, Inc., known as Judi Health, is an American health technology company that provides pharmacy and medical benefits management solutions, including pharmacy benefit management, health benefit management, care navigation, and a discount card program. The company also offers a SaaS platform for claim workflow management and operates as a public benefit corporation. Its services are designed for employers, self-funded groups, health plans, brokers, and consultants, and are supported by a network of partners and affiliates.

Description from Veridion's company data.

Products and services

Health Benefit Management Services
Pharmacy Benefit Management Services
Medical Benefit Management Services
Care Navigation Services
Health Benefits SaaS Platform Development
Claims Workflow Management Solutions
AI-Powered Health Platform Development
Healthcare Technology Solutions Development
Healthcare Partner Network Solutions

Markets

Healthcare

Technology

AI-Powered Enterprise Health Platform
Unified Claims Processing Platform

Business model

Business-to-Business
Service Provider
Software-as-a-Service
Enterprise

Industry codes (NAICS)

524292 Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds 70% match
513210 Software Publishers 30% match

Questions about Judi Health

What is Judi Health worth?

Valuation $4.2B (range $2.7B to $4.9B), as of 24 Oct 2026. The last disclosed valuation was $3.25B (Series F, Sep 2025).

Has Judi Health raised money?

Judi Health has 5 funding rounds on record, from Jul 2019 to Sep 2025, $618M in total. The latest disclosed valuation is $3.25B post-money (Series F, Sep 2025).

Who has invested in Judi Health?

Edison Partners, Transformation Capital, B Capital, General Catalyst, Wellington Management and 9Yards Capital, and 14 more. Lead investors include Edison Partners, Transformation Capital, B Capital and General Catalyst.

How many people work at Judi Health?

About 56. Headcount rose from 99 in Jan 2021 to 630 in Nov 2024, then fell to 56 in Sep 2026.

What does Judi Health do?

Judi Health works in insurance - agents, carriers & brokers, with 9 recorded offerings and customers in healthcare. Its main offerings are health benefit management services, pharmacy benefit management services and medical benefit management services.

When was Judi Health founded, and where is it based?

Judi Health was founded in 2017 and is based in Jersey City, United States. It has about 56 employees.

How we value companies Report an issue